Pharmstandard OJSC Acquires Bever Pharmaceutical Company

Pharmstandard to acquire API suppliers in Singapore

6:54 AM, 19th August 2013
Pharmstandard OJSC Business Acquisition News

MOSCOW, RUSSIA: Pharmstandard OJSC, Russia’s leading pharmaceutical company, will acquire 100 per cent share capital of Bever Pharmaceutical Pte Ltd, a Singapore based active pharmaceutical ingredients supplier. Total consideration for the acquisition is $590 million. It is expected that Bever will be included in a proposed spin-off of the company’s branded over-the-counter business.


© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Edeniq, Pacific Ag collaborate for cellulosic ethanol production

CALIFORNIA/FLORIDA, US: Edeniq, a biomaterials and sustainable fuels company, and Pacific Ag, the leader in agricultural feedstock supply chains, have ...

Read more
Mylan gets clearance for $1.6-billion takeover of Agila Specialties

NEW DELHI, INDIA: Mylan Inc gets clearance for $1.6-billion takeover of Agila Specialties after Indian Prime Minister Manmohan Singh overruled objecti ...

Read more
Boehringer Ingelheim to close API plant in Petersburg, US

PETERSBURG, US: Boehringer Ingelheim Chemicals Inc will close its Petersburg plant at the end of 2014. The facility will continue normal operations th ...

Read more
Murphy Oil appoints new President and CEO, Roger Jenkins

ARKANSAS, US: Murphy Oil Corporation has named Roger Jenkins to the position of President and Chief Executive Officer, effective from 30 August 2013. ...

Read more
BioNitrogen awards fertilizer plant contract to Casale

DORAL, US: BioNitrogen Holdings Corporation has signed an agreement with the Casale Group of Switzerland to employ its ammonia and urea plant technolo ...

Read more
Symrise, Gee Lawson extend esculin JV

HOLZMINDEN, GERMANY/LONDON, UK: Symrise BioActives and Gee Lawson are extending a cooperation, which began in 2011. Symrise BioActives manufactures hi ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X